Are you Dr. Muler?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 71 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
5308 Harroun Rd
Suite 055
Sylvania, OH 43560Phone+1 419-824-6599Fax+1 419-885-3870
Summary
- Dr. Jeffrey Muler, MD is an oncologist in Sylvania, Ohio. He is currently licensed to practice medicine in Ohio, Massachusetts, and Indiana. He is affiliated with ProMedica Toledo Hospital, Mercy Health - St. Vincent Medical Center, and St. Luke's Hospital.
Education & Training
- University of MichiganFellowship, Hematology and Medical Oncology, 2000 - 2003
- University of MichiganResidency, Internal Medicine, 1996 - 1999
- Tufts University School of MedicineClass of 1996
Certifications & Licensure
- MA State Medical License 2017 - 2026
- OH State Medical License 1999 - 2026
- VA State Medical License 1999 - 2026
- IN State Medical License 1999 - 2025
- MI State Medical License 1999 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer Start of enrollment: 2015 Aug 27
- Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer Start of enrollment: 2015 Jul 26
- Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 73 citationsPhase I Trial Using a Time-to-Event Continual Reassessment Strategy for Dose Escalation of Cisplatin Combined With Gemcitabine and Radiation Therapy in Pancreatic CancerJeffrey H. Muler, Cornelius J. McGinn, Daniel P. Normolle, Theodore Lawrence, Diane Brown
Journal of Clinical Oncology. 2004-01-15 - 47 citationsAdjuvant therapy of osteosarcoma--A Phase II trial: Southwest Oncology Group study 9139.Mark M. Zalupski, Cathryn Rankin, James R. Ryan, David R. Lucas, Jeffrey Muler
Cancer. 2004-02-15 - 21 citationsAcute megakaryocytic leukemia presenting as hypercalcemia with skeletal lytic lesionsJeffrey H. Muler, Riccardo Valdez, Curtis W. Hayes, Mark S. Kaminski
European Journal of Haematology. 2002-06-01
Professional Memberships
- Member